These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 3544863

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Alpha-adrenergic blockade improves glucose-potentiated insulin secretion in non-insulin-dependent diabetes mellitus.
    Broadstone VL, Pfeifer MA, Bajaj V, Stagner JI, Samols E.
    Diabetes; 1987 Aug; 36(8):932-7. PubMed ID: 2885238
    [Abstract] [Full Text] [Related]

  • 46. Catecholamines and pancreatic hormones during autonomic blockade in exercising man.
    Galbo H, Christensen NJ, Holst JJ.
    Acta Physiol Scand; 1977 Dec; 101(4):428-37. PubMed ID: 596218
    [Abstract] [Full Text] [Related]

  • 47. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
    Lorenzi M, Karam JH, Tsalikian E, Bohannon NV, Gerich JE, Forsham PH.
    J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
    [Abstract] [Full Text] [Related]

  • 48. Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade.
    Clarke WL, Santiago JV, Thomas L, Ben-Galim E, Haymond MW, Cryer PE.
    Am J Physiol; 1979 Feb; 236(2):E147-52. PubMed ID: 420285
    [No Abstract] [Full Text] [Related]

  • 49. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA, Vinik AI, Levitt N.
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Epinephrine and potassium homeostasis.
    DeFronzo RA, Bia M, Birkhead G.
    Kidney Int; 1981 Jul; 20(1):83-91. PubMed ID: 7300118
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.
    Galbo H, Holst JJ, Christensen NJ, Hilsted J.
    J Appl Physiol; 1976 Jun; 40(6):855-63. PubMed ID: 931921
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S, Sotsky M, Shamoon H.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [Abstract] [Full Text] [Related]

  • 58. Physical performance and serum potassium under chronic beta-blockade.
    Kullmer T, Kindermann W.
    Eur J Appl Physiol Occup Physiol; 1985 Jan; 54(4):350-4. PubMed ID: 2998786
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W, Hausen M, Krämer B, Kübler W.
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.